GFACX
Price
$65.90
Change
+$0.75 (+1.15%)
Updated
Jan 17 closing price
Net Assets
306.54B
RAFEX
Price
$43.06
Change
+$0.36 (+0.84%)
Updated
Jan 17 closing price
Net Assets
90.68B
Ad is loading...

GFACX vs RAFEX

Header iconGFACX vs RAFEX Comparison
Open Charts GFACX vs RAFEXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.90
Change+$0.75 (+1.15%)
VolumeN/A
Net Assets306.54B
American Funds AMCAP R4
Price$43.06
Change+$0.36 (+0.84%)
VolumeN/A
Net Assets90.68B
GFACX vs RAFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. RAFEX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and RAFEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 307B vs. RAFEX (90.7B). RAFEX pays higher dividends than GFACX: RAFEX (0.48) vs GFACX (0.00). GFACX was incepted earlier than RAFEX: GFACX (24 years) vs RAFEX (23 years). GFACX (31.00) and RAFEX (31.00) have comparable annual turnover. GFACX (250) and RAFEX (250) have matching initial minimum investment requirements. GFACX annual gain was more profitable for investors over the last year : 19.88 vs. RAFEX (14.47). GFACX return over 5 years is better than : 36.07 vs. RAFEX (26.48).
GFACXRAFEXGFACX / RAFEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years23 years-
Gain YTD3.3562.111159%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets307B90.7B338%
Annual Yield % from dividends0.000.48-
Returns for 1 year19.8814.47137%
Returns for 3 years7.806.10128%
Returns for 5 years36.0726.48136%
Returns for 10 years65.6259.63110%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCC56.061.70
+3.13%
Warrior Met Coal
BEKE17.100.41
+2.46%
KE Holdings
STRR2.290.02
+0.88%
Star Equity Holdings Inc.
TYRA16.190.04
+0.25%
Tyra Biosciences
IKT2.72-0.04
-1.45%
Inhibikase Therapeutics